Table 1 Demographic and clinical data.
All | Male patients | Female patients | |||
|---|---|---|---|---|---|
n | 78 | 38 | 40 | ||
Age (y) | 78 | 71 [66, 75] | 70 [64, 75] | 73 [67, 75] | |
ALSFRS-R score | 69 | 41.00 [36, 44] | 38 [35, 43] | 42 [39, 44] | |
ΔALSFRS-R | 69 | 0.56 [0.27, 1.00] | 0.56 [0.26, 1.00] | 0.52 [0.31, 0.87] | |
BMI at the first visit (kg/m2) | 78 | 21.7 [18.7, 24.1] | 22.1 [20.0, 24.5] | 20.8 [18.5, 23.4] | |
ΔBMI | 74 | 0.19 [0.01, 0.33] | 0.18 [0.01, 0.43] | 0.20 [0.07, 0.31] | |
Bulbar type (yes) | 26/78 (33%) | 11/38 (29%) | 15/40 (38%) | ||
Hypermetabolism (yes) | 25/53 (47%) | 9/24 (38%) | 16/29 (55%) | ||
mREE/LSTM (kcal/kg) | 53 | 37.1 [34.5, 41.2] | 35.6 [34.0, 39.2] | 38.7 [34.5, 42.6] | |
Statin use (yes) | 21/78 | 7/38 (18%) | 14/40 (35%) | ||
%VC (%) | 70 | 88 [78, 95] | 90 [81, 99] | 87 [72, 95] | |
Endpoint | 41/78 | 22/38 | 19/40 | ||
Blood test for the first time | p* | ||||
HDL (mg/dL) | 78 | 63 [50, 75] | 60 [49, 71] | 65 [57, 76] | 0.175 |
High HDL | 23 | 10/38 (26%) | 13/40 (33%) | 0.62 | |
LDL (mg/dL) | 78 | 115 [96, 139] | 111 [80, 125] | 129 [104, 143] | 0.008 |
Low LDL | 19 | 10/38 (26%) | 9/40 (23%) | 0.79 | |
TG (mg/dL) | 77 | 109 [74, 143] | 120 [76, 164] | 103 [73, 136] | 0.51 |
Low TG | 20 | 9/38 (24%) | 11/39 (28%) | 0.80 | |
Interval between the onset and | |||||
blood test (months) | 78 | 9.00 [6.00, 13] |